LABCORP HOLDINGS INC. Deferred Revenue, Revenue Recognized
LABCORP HOLDINGS INC. (LH) reported Deferred Revenue, Revenue Recognized of $34.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2026-08-05
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for the quarter ending 2026-06-30 was $34.10M, a 0.87% decline year-over-year.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for the quarter ending 2026-03-31 was $58.30M, a 15.38% decline year-over-year.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for the quarter ending 2025-09-30 was $16.00M, a 20.79% decline year-over-year.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for the quarter ending 2025-06-30 was $34.40M, a 28.36% increase year-over-year.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for fiscal 2025 was $129.50M, a 14.60% increase from fiscal 2024.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for fiscal 2024 was $113.00M, a 43.22% increase from fiscal 2023.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for fiscal 2023 was $78.90M, a 20.86% decline from fiscal 2022.
- LABCORP HOLDINGS INC. deferred revenue, revenue recognized for fiscal 2022 was $99.70M, a 9.94% decline from fiscal 2021.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 3 month as first filed | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 6 month as first filed | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 9 month as first filed | Deferred Revenue, Revenue Recognized 12 month | Deferred Revenue, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $34.10M 10-Q · filed 2026-08-05 | $92.40M 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | $58.30M 10-Q · filed 2026-05-04 | |||||||
| 2025-12-31 | $129.50M 10-K · filed 2026-02-24 | |||||||
| 2025-09-30 | $16.00M 10-Q · filed 2025-10-31 | $119.30M 10-Q · filed 2025-10-31 | ||||||
| 2025-06-30 | $34.40M 10-Q · filed 2026-08-05 | $103.30M 10-Q · filed 2026-08-05 | ||||||
| 2025-03-31 | $68.90M 10-Q · filed 2026-05-04 | |||||||
| 2024-12-31 | $113.00M 10-K · filed 2026-02-24 | |||||||
| 2024-09-30 | $20.20M 10-Q · filed 2025-10-31 | $98.00M 10-Q · filed 2025-10-31 | ||||||
| 2024-06-30 | $26.80M 10-Q · filed 2025-08-01 | $77.80M 10-Q · filed 2025-08-01 | ||||||
| 2024-03-31 | $51.00M 10-Q · filed 2025-04-29 | |||||||
| 2023-12-31 | $78.90M 10-K · filed 2026-02-24 | |||||||
| 2023-09-30 | $6.30M 10-Q · filed 2024-10-29 | $79.10M 10-Q · filed 2024-10-29 | ||||||
| 2023-06-30 | $20.20M 10-Q · filed 2024-08-02 | $72.80M 10-Q · filed 2024-08-02 | ||||||
| 2023-03-31 | $52.60M 10-Q · filed 2024-04-30 | $165.30M 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | $99.70M 10-K · filed 2025-02-25 | $330.50M 10-K · filed 2023-02-28 | ||||||
| 2022-09-30 | $9.30M 10-Q · filed 2023-10-30 | $65.90M 10-Q · filed 2023-10-30 | $277.90M 10-Q · filed 2022-11-01 | |||||
| 2022-06-30 | $56.60M 10-Q · filed 2023-08-04 | $233.60M 10-Q · filed 2022-08-01 | ||||||
| 2022-03-31 | $163.80M 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | $110.70M 10-K · filed 2024-02-26 | $319.40M 10-K · filed 2022-02-25 | ||||||
| 2021-09-30 | $267.60M 10-Q · filed 2022-11-01 | |||||||
| 2021-06-30 | $233.00M 10-Q · filed 2022-08-01 | |||||||
| 2021-03-31 | $152.30M 10-Q · filed 2022-04-29 | |||||||
| 2020-12-31 | $262.60M 10-K · filed 2023-02-28 | |||||||
| 2020-09-30 | $237.20M 10-Q · filed 2021-11-02 | |||||||
| 2020-06-30 | $102.20M 10-Q · filed 2021-08-05 | |||||||
| 2020-03-31 | $121.80M 10-Q · filed 2021-05-04 | |||||||
| 2019-12-31 | $250.20M 10-K · filed 2022-02-25 | |||||||
| 2019-09-30 | $232.80M 10-Q · filed 2020-10-29 | |||||||
| 2019-06-30 | $161.60M 10-Q · filed 2020-07-31 | |||||||
| 2019-03-31 | $103.60M 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $204.00M 10-K · filed 2020-02-28 | |||||||
| 2018-09-30 | $144.80M 10-Q · filed 2019-10-31 | |||||||
| 2018-06-30 | $135.60M 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | $71.00M 10-Q · filed 2018-05-01 | |||||||
| 2017-06-30 | $101.60M 10-Q · filed 2018-07-27 | |||||||
| 2017-03-31 | $55.10M 10-Q · filed 2018-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |